Showing results (11-20 of 45) with videos related to

Sort By:
Pageof 5
Journal of Cardiovascular Pharmacology|March 3, 2021
The Angiotensin II Type 1(AT1) Receptor and Cardiac Hypertrophy: Did We Have It Wrong All Along?Fouad A Zouein, Raffaele Altara, Gaelle P Massoud, et al.
Journal of Cardiovascular Pharmacology|December 13, 2016
Update on the Protective Role of Regulatory T Cells in Myocardial Infarction: A Promising Therapy to Repair the HeartAbdullah Kaplan, Raffaele Altara, Ali Eid, et al.
Frontiers in Physiology|July 26, 2021
Atrial Natriuretic Peptide31-67: A Novel Therapeutic Factor for Cardiovascular DiseasesGustavo Jose Justo da Silva, Raffaele Altara, George W Booz, et al.
IUBMB Life|August 14, 2015
The circular relationship between matrix metalloproteinase-9 and inflammation following myocardial infarctionKristine Y Deleon-Pennell, Raffaele Altara, Andriy Yabluchanskiy, et al.
Frontiers in Pharmacology|December 1, 2016
Cardiac STAT3 Deficiency Impairs Contractility and Metabolic Homeostasis in HypertensionRaffaele Altara, Romain Harmancey, Sean P Didion, et al.
European Journal of Pharmacology|February 3, 2022
Role of ranolazine in heart failure: From cellular to clinic perspectiveAbdullah Kaplan, Ghadir Amin, Emna Abidi, et al.
Bioscience Reports|August 1, 2018
Cerebral blood flow alteration following acute myocardial infarction in miceAbdullah Kaplan, Andriy Yabluchanskiy, Rana Ghali, et al.
Cardiovascular Research|July 9, 2018
Conflicting vascular and metabolic impact of the IL-33/sST2 axisRaffaele Altara, Rana Ghali, Ziad Mallat, et al.
Heart Failure Reviews|October 27, 2015
Temporal cardiac remodeling post-myocardial infarction: dynamics and prognostic implications in personalized medicineRaffaele Altara, Marco Manca, Ramzi Sabra, et al.
Clinical Science (London, England : 1979)|February 19, 2016
Emerging importance of chemokine receptor CXCR3 and its ligands in cardiovascular diseasesRaffaele Altara, Marco Manca, Rita D Brandão, et al.
Pageof 5